Mariano
Ponz Sarvisé
Consultor Médico
Javier
Rodríguez Rodríguez
Consultor Médico
Publicaciones en las que colabora con Javier Rodríguez Rodríguez (11)
2023
-
Liver Resection and Transplantation Following Yttrium-90 Radioembolization for Primary Malignant Liver Tumors: A 15-Year Single-Center Experience
Cancers, Vol. 15, Núm. 3
-
Therapeutic drug monitoring of neoadjuvant mFOLFIRINOX in resected pancreatic ductal adenocarcinoma
Pancreatology, Vol. 23, Núm. 4, pp. 411-419
2019
2018
-
A randomized phase II clinical trial of dendritic cell vaccination following complete resection of colon cancer liver metastasis 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis
Journal for ImmunoTherapy of Cancer, Vol. 6, Núm. 1
-
Adjuvant therapy for colon cancer: Genes, genes. . . And the patient in the center
Clinical Cancer Research, Vol. 24, Núm. 16, pp. 3787-3789
2016
-
Role of histological regression grade after two neoadjuvant approaches with or without radiotherapy in locally advanced gastric cancer
British Journal of Cancer, Vol. 115, Núm. 6, pp. 655-663
2011
-
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy
European Journal of Cancer, Vol. 47, Núm. 6, pp. 839-847
2010
-
Dose-finding study and pharmacogenomic analysis of fixed-rate infusion of gemcitabine, irinotecan and bevacizumab in pretreated metastatic colorectal cancer patients
British Journal of Cancer, Vol. 103, Núm. 10, pp. 1529-1535
-
Improving disease control in advanced colorectal cancer: Panitumumab and cetuximab
Critical Reviews in Oncology/Hematology, Vol. 74, Núm. 3, pp. 193-202
-
Oxaliplatin, irinotecan and capecitabine as first-line therapy in metastatic colorectal cancer (mCRC): A dose-finding study and pharmacogenomic analysis
British Journal of Cancer, Vol. 102, Núm. 6, pp. 987-994
2007
-
Epidermal growth factor receptor inhibitors in colorectal cancer treatment: What's new?
World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5877-5887